We worked with brands like Netflix, Maui Jim, eBay, Workday, Tenable and GE, as well as startups and PE backed growth companies on paid media acquisition. We leverage data to rapidly improve campaign performance.40%+ reduction in CAC from instituting analytcal methodologies and best practice technologies.We welcome new conversations, feel free to reach out here or on our site.The founder has authored a book on digital marketing and neuroscience. (Link below)https://www.amazon.com/Conversion-Rate-Optimization-Neuroscience-Conversions/dp/1083088874

I help clients win more customers, turning traffic into revenue by improving conversion and retention through best practice e-tailing and A/B testing. My clients range from startups to Top 10 internet companies. Collectively they comprise over 10% of U.S. internet traffic.Representative customer work includes:• Leading SaaS Company - developed and implemented e-commerce strategy, increasing conversions >50%.• Top 5 Internet Media Co. - developed global conversion strategy spanning multiple sites and languages. Directed efforts for company's $50M products, dramatically increasing conversions.• Online Home Improvement site - increased lead form conversion rate by 88%.• Healthcare Provider - reimagined website experience based on extensive customer research and validated with A/B testing. Won 600% increase in online customer acquisition.

Led international growth strategy and oncology pipeline development for a 750 person healthcare diagnostics company with >$XXX million in revenue and annualized revenue growth of >XX% over the past three years.Oncology marketing transformation: created direct to consumer message and market plan, complete web redesign.• Transformed Caris web and physician marketing message, new focus on DTC; planned changes currently being executed against.• Led business planning and analysis of >$XXM investment in new oncology offering.• Designed marketing presentations to support $XM physician sales meetings and BD activities.Led international growth strategy, developed relationships with EU government to garner commitment for >$XXM in financing for R&D.Directed all business development activity across Caris businesses. • Managed a sensitive 3-way negotiation resulting in the successful execution of a $XXM acquisition of molecular start-up. • Acquired game changing diagnostic platform technology within 3 months of starting role. Grew team to 6 direct reports.• Presented more than 15 opportunities to the Board of Directors within 2 months of joining Caris and received endorsement of the strategy.

Crafted strategy overhaul for >$1B molecular diagnostics business which led to aggressive operational improvement initiatives; led cross functional teams during business development deal making, including large scale M&A, partnerships/collaborations, supply and distribution deals.

Led client teams in full range of primarily marketing and sales related engagements.Selected engagements included:• Led components of a client team in sales force restructuring for a leading medical device company; company achieved ~30% annual growth. Rolled out toolkit for management use in all 110 U.S. territories. • Analyzed new market opportunities for $20B wireless carrier for US market entry. Identified opportunities in the consumer health space, vetting opportunities with in-depth focus groups and market surveys. Senior management approved $20M trial roll out.• Assessed potential for a ~$200M web-based real estate opportunity; discovered client had overestimated market potential by ~100%.• Identified additional ~$40M in revenue through pricing strategies in four channels and three customer segments for medical device manufacturer. Discovered underestimation of new competitor sales by >300%.• Assessed ophthalmology prescription drug strategy for leading ophthalmology company, addressing >$200M in revenue shortfall over a five year period.• Identified market opportunities for a $4B medical device company. Discovered client had overestimated diabetes market size by >100%; analysis deterred SEC investigation.• Analyzed remote health monitoring for $20B wireless carrier for US market entry. Presented recommendations to senior management, received approval for $20M trial roll out.• Assessed ~$1B acquisition for medical device company. Recommended against acquisition due to >$20M in potential retail channel backlash; recommendation accepted by CEO.• Evaluated $250M healthcare investment opportunity; results presented to Governor.

Analyzed potential deal structure for merger of IT firms with $37 billion in total revenue.

Started and ran retail services operations.